DOCS
Doximity, Inc.
NYSEUSDEQUITY
Healthcare
DELAYED
Buy
+33/100
Last price
28.00
▼ 0.58 (2.03%)
MARKET · —
Price
Chart style
Interval
Intraday intervals only cover recent history. The site picks the finest interval the range allows.
Overlays
Session levels
Lower pane
Overlay another symbol
Both series are rebased to 0% at the left edge, so the lines show relative performance rather than price.
Tool
1D
—
H —
L —
Range —
Vol —
vs
Drag pan · Pinch zoom · Hold crosshair · pick a tool then drag to draw
Open
28.91
Prev close
28.58
Day high
29.20
Day low
27.71
Volume
2.31M
Market cap
$4.95B
P/E (TTM)
33.48
52W range
17.15 – 73.92
Day trading desk
Gap from prior close
+1.15%
Prior close 28.58
VWAP
28.18
-0.64% from price
Relative volume
1.51×
Unusually busy
Session range
5.81%
27.71 – 29.32
Position in range
18%
Near session low
ATR (14D)
1.13
4.04% of price
Prior day high
28.90
PDH
Prior day low
28.01
PDL
Bid / ask spread
—
Quote not published
Session volume
6.67M
Avg 4.43M
VWAP and the session figures are computed from the delayed intraday series on this page, so they lag the live tape and will not match a broker's real-time VWAP exactly. Turn on Prior day H/L/C, Opening range and Volume profile in the chart's Studies menu to see these levels drawn on price.
Trailing performance
Returnvs SPY
1W
+4.79%
+2.8%
1M
+5.46%
+4.3%
3M
+28.12%
+23.6%
6M
+23.51%
+5.3%
YTD
-37.24%
-51.5%
1Y
-62.07%
-78.5%
3Y
+30.96%
-51.3%
5Y
—
—
Price return only. Dividends are not reinvested, so total return on a dividend payer will be higher than shown.
Unusual options activity
Nothing crossed the thresholds in the expiries we scanned.
That is the normal state — most contracts trade well inside their existing open interest.
That is the normal state — most contracts trade well inside their existing open interest.
Contracts trading at or above their open interest, ranked by notional and where the print landed.
Free account
5 more panels on DOCS open with an account.
Options chains and analytics, valuation ratios, insider filings, analyst targets and ownership. No card, no trial, nothing to cancel.
Insider net activity
Net shares
+619.09K
Net buying
Buy transactions
21
654.35K shares
Sell transactions
11
35.26K shares
Net transactions
+32
Buys less sells
Sell : buy shares
0.1 : 1
Mixed
Insider-held shares
5.31M
Total on file
Insider transactions
| Date | Insider | Action | Shares | Value | Held |
|---|---|---|---|---|---|
| Oct 1, 26 | WAMPLER KIRA SCHERER Director |
— | 2.00K | — | Direct |
| Oct 1, 26 | WAMPLER KIRA SCHERER Director |
SELL | 2.00K | $57.82K | Direct |
| Sep 24, 26 | ZATZ STEVEN L. M.D. President |
STOCK | 152.43K | $0 | Direct |
| Sep 15, 26 | SITARAM SIDDHARTH Officer |
— | 5.00K | — | Direct |
| Sep 15, 26 | SITARAM SIDDHARTH Officer |
SELL | 2.08K | $54.04K | Direct |
| Sep 1, 26 | WAMPLER KIRA SCHERER Director |
— | 2.00K | — | Direct |
| Sep 1, 26 | WAMPLER KIRA SCHERER Director |
SELL | 2.00K | $52.66K | Direct |
| Aug 27, 26 | CABRAL TIMOTHY S Director |
STOCK | 8.08K | $0 | Direct |
| Aug 27, 26 | SPAIN KEVIN Director |
STOCK | 8.08K | $0 | Direct |
| Aug 27, 26 | BENJAMIN REGINA M. Director |
STOCK | 8.08K | $0 | Direct |
| Aug 27, 26 | WAMPLER KIRA SCHERER Director |
STOCK | 8.08K | $0 | Direct |
| Aug 27, 26 | YANG WATKIN PHOEBE L Director |
STOCK | 8.08K | $0 | Direct |
| Aug 25, 26 | WAMPLER KIRA SCHERER Director |
— | 2.00K | — | Direct |
| Aug 25, 26 | WAMPLER KIRA SCHERER Director |
SELL | 2.00K | $49.90K | Direct |
What this is, and what it is not
These are SEC Form 4 filings — officers, directors and 10% owners reporting their own trades in the company's stock. Filing is due within two business days of the transaction, so this lags reality by days, and the provider adds its own lag on top.
A sale is not automatically bearish. Executives sell on scheduled 10b5-1 plans, to cover tax on vesting equity, and to diversify. Purchases with cash are generally the more informative signal, and they are far rarer.
This does not include congressional or senate trading. That comes from STOCK Act disclosures filed with the Senate eFD system and the House Clerk, which this data source does not carry.
Officer and director trades in their own stock, straight from Form 4 filings.
Insider holders
| Name | Relation | Shares held | Latest |
|---|---|---|---|
BENJAMIN REGINA M. |
Director | 58.99K | Stock Award(Grant) |
BRYSON ANNA COLLINS |
Chief Financial Officer | 505.55K | Stock Award(Grant) |
CABRAL TIMOTHY S |
Director | 11.30K | Stock Award(Grant) |
SITARAM SIDDHARTH |
Officer | 96.05K | Conversion of Exercise of derivative security |
SPAIN KEVIN |
Director | 644.75K | Stock Award(Grant) |
TANGNEY JEFFREY A. |
Chief Executive Officer | 2.54M | Stock Award(Grant) |
WAMPLER KIRA SCHERER |
Director | 27.92K | Conversion of Exercise of derivative security |
YANG WATKIN PHOEBE L |
Director | 26.03K | Stock Award(Grant) |
ZATZ STEVEN L. M.D. |
President | 204.29K | Stock Award(Grant) |
Fundamentals
Market cap$4.95B
Enterprise value$4.28B
Revenue (TTM)$655.57M
Gross profit$577.34M
EBITDA$208.40M
Net income$167.05M
EPS (TTM)$0.83
Free cash flow$239.70M
Total cash$687.79M
Total debt$9.67M
Book value / share$5.09
Shares outstanding127.35M
Float123.64M
Short % of float9.93%
Dividend yield0.00%
Beta (5Y)1.22
Valuation & profitability ratios
Trailing P/E33.48
Forward P/E17.85
PEG ratio0.59
Price / sales—
Price / book5.46
EV / revenue6.52
EV / EBITDA20.52
Gross margin88.07%
Operating margin21.54%
Profit margin25.48%
Return on equity17.21%
Return on assets10.95%
Debt / equity1.06
Current ratio6.08
Fourteen ratios including P/E, PEG, EV/EBITDA, margins and return on equity.
Financial statements
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Total revenue | $644.86M | $570.40M | $475.42M | $419.05M | +13.1% |
| Operating revenue | $608.41M | $543.77M | $450.07M | $389.74M | +11.9% |
| Cost of revenue | $70.33M | $55.87M | $50.67M | $53.49M | +25.9% |
| Gross profit | $574.54M | $514.52M | $424.75M | $365.56M | +11.7% |
| Research & development | $130.70M | $93.04M | $81.98M | $80.19M | +40.5% |
| Selling, general & admin | $228.91M | $191.38M | $170.96M | $160.27M | +19.6% |
| Total operating expense | $359.62M | $284.42M | $252.94M | $240.45M | +26.4% |
| Operating income | $214.92M | $230.10M | $171.81M | $125.11M | -6.6% |
| Net interest income | $35.70M | $35.85M | $21.66M | $9.29M | -0.4% |
| Pre-tax income | $250.00M | $263.57M | $185.20M | $133.16M | -5.1% |
| Tax provision | $53.95M | $40.39M | $37.62M | $20.34M | +33.6% |
| Net income | $196.05M | $223.19M | $147.58M | $112.82M | -12.2% |
| Net income to common | $196.05M | $223.19M | $147.58M | $112.82M | -12.2% |
| Basic EPS | 1.05 | 1.19 | 0.78 | 0.58 | -11.8% |
| Diluted EPS | 0.98 | 1.11 | 0.72 | 0.53 | -11.7% |
| EBIT | $214.92M | $230.10M | $171.81M | $125.11M | -6.6% |
| EBITDA | $229.30M | $240.76M | $182.08M | $135.39M | -4.8% |
| Basic shares | 187.01M | 186.84M | 190.17M | 193.18M | +0.1% |
| Diluted shares | 199.05M | 201.21M | 205.73M | 213.43M | -1.1% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Cash & equivalents | $219.18M | $209.61M | $96.78M | $158.03M | +4.6% |
| Cash & short-term investments | $748.60M | $915.66M | $762.90M | $841.00M | -18.2% |
| Accounts receivable | $144.78M | $128.35M | $101.33M | $107.05M | +12.8% |
| Total current assets | $944.26M | $1.09B | $912.94M | $975.45M | -13.3% |
| Property, plant & equipment | $25.22M | $22.54M | $24.65M | $25.10M | +11.9% |
| Goodwill & intangibles | $120.30M | $91.01M | $95.26M | $99.78M | +32.2% |
| Total assets | $1.12B | $1.26B | $1.08B | $1.14B | -11.1% |
| Total current liabilities | $154.97M | $156.26M | $147.25M | $139.51M | -0.8% |
| Total debt | $10.19M | $12.40M | $14.55M | $15.64M | -17.8% |
| Total liabilities | $172.85M | $181.68M | $177.98M | $170.77M | -4.9% |
| Retained earnings | -$51.06M | $186.89M | $79.99M | $217.85M | -127.3% |
| Shareholder equity | $950.84M | $1.08B | $901.40M | $966.12M | -12.2% |
| Working capital | $789.29M | $932.36M | $765.69M | $835.95M | -15.3% |
| Net tangible assets | $830.54M | $991.61M | $806.14M | $866.34M | -16.2% |
| Shares issued | 183.06M | 188.88M | 186.56M | 193.94M | -3.1% |
| Line item | 2026 | 2025 | 2024 | 2023 | YoY |
|---|---|---|---|---|---|
| Net income | $196.05M | $223.19M | $147.58M | $112.82M | -12.2% |
| Depreciation & amortisation | $14.38M | $10.66M | $10.27M | $10.28M | +34.9% |
| Stock-based compensation | $121.63M | $72.39M | $51.08M | $47.83M | +68.0% |
| Change in working capital | -$45.70M | -$24.10M | -$24.52M | -$21.03M | -89.6% |
| Operating cash flow | $326.46M | $273.26M | $184.10M | $179.60M | +19.5% |
| Capital expenditure | -$8.96M | -$6.53M | -$5.80M | -$6.18M | -37.4% |
| Investing cash flow | $147.17M | -$29.30M | $31.19M | -$59.92M | +602.3% |
| Share buybacks | -$431.65M | -$120.29M | -$280.72M | -$85.32M | -258.8% |
| Financing cash flow | -$464.06M | -$131.14M | -$276.52M | -$74.46M | -253.9% |
| Free cash flow | $317.50M | $266.74M | $178.29M | $173.42M | +19.0% |
| End cash position | $219.18M | $209.61M | $96.78M | $158.03M | +4.6% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Total revenue | $156.62M | $145.37M | $185.05M | $168.53M | $145.91M | +7.7% |
| Operating revenue | $146.30M | $135.69M | $175.38M | $159.47M | $137.88M | +7.8% |
| Cost of revenue | $23.69M | $19.41M | $18.70M | $16.43M | $15.79M | +22.1% |
| Gross profit | $132.93M | $125.97M | $166.35M | $152.10M | $130.12M | +5.5% |
| Research & development | $38.48M | $39.11M | $34.59M | $30.20M | $26.80M | -1.6% |
| Selling, general & admin | $60.80M | $62.03M | $59.86M | $58.22M | $48.80M | -2.0% |
| Total operating expense | $99.28M | $101.14M | $94.46M | $88.42M | $75.60M | -1.8% |
| Operating income | $33.64M | $24.83M | $71.90M | $63.68M | $54.52M | +35.5% |
| Net interest income | $6.94M | $7.46M | $8.94M | $9.44M | $9.87M | -7.0% |
| Pre-tax income | $40.36M | $32.12M | $80.80M | $72.94M | $64.15M | +25.7% |
| Tax provision | $16.05M | $13.01M | $19.24M | $10.88M | $10.83M | +23.4% |
| Net income | $24.32M | $19.11M | $61.56M | $62.06M | $53.32M | +27.2% |
| Net income to common | $24.32M | $19.11M | $61.56M | $62.06M | $53.32M | +27.2% |
| Basic EPS | 0.13 | 0.10 | 0.33 | 0.33 | 0.28 | +30.0% |
| Diluted EPS | 0.13 | 0.10 | 0.31 | 0.31 | 0.27 | +30.0% |
| EBIT | $33.64M | $24.83M | $71.90M | $63.68M | $54.52M | +35.5% |
| EBITDA | $37.93M | $28.96M | $75.89M | $67.15M | $57.31M | +31.0% |
| Basic shares | 182.57M | 184.85M | 187.48M | 187.71M | 187.98M | -1.2% |
| Diluted shares | 191.17M | 195.03M | 199.22M | 200.75M | 201.16M | -2.0% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Cash & equivalents | $273.60M | $219.18M | $64.84M | $169.25M | $137.26M | +24.8% |
| Cash & short-term investments | $687.79M | $748.60M | $735.13M | $878.37M | $840.97M | -8.1% |
| Accounts receivable | $177.57M | $144.78M | $156.59M | $129.31M | $141.66M | +22.6% |
| Total current assets | $913.98M | $944.26M | $993.45M | $1.09B | $1.03B | -3.2% |
| Property, plant & equipment | $26.00M | $25.22M | $24.58M | $23.69M | $22.71M | +3.1% |
| Goodwill & intangibles | $118.36M | $120.30M | $122.24M | $124.12M | $90.01M | -1.6% |
| Total assets | $1.08B | $1.12B | $1.16B | $1.26B | $1.20B | -3.5% |
| Total current liabilities | $150.36M | $154.97M | $149.85M | $140.27M | $159.91M | -3.0% |
| Total debt | $9.67M | $10.19M | $10.69M | $11.27M | $11.84M | -5.0% |
| Total liabilities | $167.78M | $172.85M | $177.73M | $161.58M | $178.85M | -2.9% |
| Retained earnings | -$119.04M | -$51.06M | $20.97M | $157.69M | $117.11M | -133.1% |
| Shareholder equity | $916.07M | $950.84M | $979.30M | $1.10B | $1.03B | -3.7% |
| Working capital | $763.62M | $789.29M | $843.61M | $951.93M | $874.32M | -3.3% |
| Net tangible assets | $797.71M | $830.54M | $857.06M | $971.41M | $935.59M | -4.0% |
| Shares issued | 179.85M | 183.06M | 184.99M | 188.09M | 187.45M | -1.8% |
| Line item | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | YoY |
|---|---|---|---|---|---|---|
| Net income | $24.32M | $19.11M | $61.56M | $62.06M | $53.32M | +27.2% |
| Depreciation & amortisation | $4.29M | $4.13M | $3.99M | $3.47M | $2.79M | +3.8% |
| Stock-based compensation | $36.75M | $36.74M | $33.55M | $29.47M | $21.86M | +0.0% |
| Change in working capital | -$27.15M | $13.80M | -$39.69M | -$2.48M | -$17.33M | -296.7% |
| Operating cash flow | $41.99M | $109.52M | $60.89M | $93.94M | $62.10M | -61.7% |
| Capital expenditure | -$2.38M | -$2.25M | -$2.38M | -$2.37M | -$1.97M | -5.8% |
| Investing cash flow | $112.99M | $137.98M | $38.23M | -$31.71M | $2.68M | -18.1% |
| Share buybacks | -$91.63M | -$90.53M | -$196.88M | -$21.89M | -$122.36M | -1.2% |
| Financing cash flow | -$100.55M | -$93.16M | -$203.53M | -$30.25M | -$137.13M | -7.9% |
| Free cash flow | $39.60M | $107.27M | $58.52M | $91.58M | $60.13M | -63.1% |
| End cash position | $273.60M | $219.18M | $64.84M | $169.25M | $137.26M | +24.8% |
Options analytics
Put / call volume
1.64
Put-heavy session
Put / call open interest
0.28
Positioning, not flow
Max pain
25.00
-10.0% from spot
ATM implied vol
52.0%
Nearest strike to spot
Skew (10% OTM)
+5.3%
Puts bid over calls
Call volume
72
Contracts, this expiry
Put volume
118
Contracts, this expiry
Heaviest call OI
25.00
1.01K contracts
Heaviest put OI
27.50
506 contracts
Max pain is the strike at which the largest dollar value of open contracts expires worthless. It describes current positioning; it is not a forecast and it moves as open interest changes.
Put/call ratios, max pain, implied volatility skew and where open interest is concentrated.
Earnings
Reported vs expected · EPS
| Quarter | Est. | Actual | Surprise |
|---|---|---|---|
| Jun 2026 | 0.30 | 0.29 | -4.2% |
| Mar 2026 | 0.28 | 0.26 | -7.9% |
| Dec 2025 | 0.45 | 0.46 | +2.9% |
| Sep 2025 | 0.38 | 0.45 | +18.7% |
Forward consensus
| Period | EPS | Analysts | Revenue | Growth |
|---|---|---|---|---|
| Current quarter | 0.35 | 18 | $170.82M | +1.4% |
| Next quarter | 0.42 | 18 | $194.85M | +5.3% |
| Current year | 1.35 | 18 | $677.34M | +5.0% |
| Next year | 1.56 | 17 | $722.35M | +6.6% |
Analyst targets & ownership
Mean target$29.67
High target$47.00
Low target$18.00
Implied upside5.95%
Analyst count18
ConsensusHOLD
Strong buy / Buy5 / 3
Hold11
Sell / Strong sell1 / 1
Held by insiders2.98%
Held by institutions102.31%
Institutions holding514
Price targets, consensus spread, insider and institutional ownership.
Moving averages & technicals
SMA 10
27.28
+2.63% from price
SMA 20
26.57
+4.58% from price
SMA 50
25.38
+9.51% from price
SMA 100
23.09
+21.25% from price
SMA 200
26.63
+4.34% from price
EMA 12
27.34
+2.42% from price
EMA 26
26.56
+5.41% from price
EMA 50
25.57
+9.52% from price
RSI (14)
58.2
Neutral
MACD (12,26,9)
0.78
Hist 0.12
ATR (14)
1.13
4.08% of price
Realised vol 30D
43.7%
Annualised
Bollinger upper
28.86
20, 2σ
Bollinger lower
24.29
20, 2σ
50 / 200 cross
Death
25.38 vs 26.63
Trend bias
Above 200
+4.34%
Options chain
Calls
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Puts
| Strike | Last | Bid | Ask | Vol | OI | IV |
|---|---|---|---|---|---|---|
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
| 000.00 | 0.00 | 0.00 | 0.00 | 0 | 0 | 0.0% |
Every listed expiry, both sides of the book, with volume, open interest and implied volatility.
Risk profile
Beta vs SPY
0.68
Less volatile than market
Correlation to SPY
0.14
Largely independent
Realised vol 30D
43.7%
Annualised
Market vol 1Y
13.0%
SPY, annualised
Max drawdown 1Y
-75.5%
Peak to trough
Max drawdown 5Y
-78.3%
Peak to trough
ATR 14
1.13
4.08% of price
Beta (reported)
1.22
5Y monthly, from filing
Short interest
Shares short
12.38M
Prior 18.43M
Change vs prior
-32.8%
Shorts covering
% of float
9.93%
Normal
% of shares out
6.95%
Against total outstanding
Days to cover
4.6
Liquid
Float
123.64M
Freely tradeable shares
Exchanges publish short interest twice a month with a settlement lag, so this is roughly two weeks behind. Days to cover divides shares short by average daily volume — it estimates how long covering would take, not whether it will happen.
Rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Sep 29, 26 | Evercore ISI Group | MAINTAINED | In-Line | In-Line |
| Sep 8, 26 | Freedom Capital Markets | DOWNGRADE | Buy | Hold |
| Aug 21, 26 | Barclays | MAINTAINED | Equal-Weight | Equal-Weight |
| Aug 13, 26 | Truist Securities | MAINTAINED | Hold | Hold |
| Aug 10, 26 | Wells Fargo | DOWNGRADE | Equal-Weight | Underweight |
| Aug 7, 26 | JP Morgan | MAINTAINED | Neutral | Neutral |
| Aug 7, 26 | Piper Sandler | MAINTAINED | Overweight | Overweight |
| Aug 7, 26 | Evercore ISI Group | MAINTAINED | In-Line | In-Line |
| Jun 29, 26 | B of A Securities | DOWNGRADE | Buy | Underperform |
| May 15, 26 | Goldman Sachs | MAINTAINED | Neutral | Neutral |
| May 15, 26 | Barclays | DOWNGRADE | Overweight | Equal-Weight |
| May 14, 26 | Leerink Partners | MAINTAINED | Outperform | Outperform |
Dividends & splits
Forward rate—
Forward yield0.00%
5-year avg yield—
Payout ratio0.00%
Ex-dividend date—
Next pay date—
Last split—
Split date—
SEC filings
Corporate Changes & Voting Matters
8-K · 2026-09-02
Corporate Changes & Voting Matters
8-K · 2026-08-06
Proxy Statements
DEFA14A · 2026-07-15
Periodic Financial Reports
10-K · 2026-05-19
Corporate Changes & Voting Matters
8-K · 2026-05-13
Corporate Changes & Voting Matters
8-K · 2026-04-17
A correspondence can be sent as a document with another submission type or can be sent as a separate submission
CORRESP · 2026-03-23
Corporate Changes & Voting Matters
8-K · 2026-02-05
Headlines
Doximity (DOCS) Surpasses Market Returns: Some Facts Worth Knowing
Zacks · 1d ago
Reasons to Retain Doximity Stock in Your Portfolio for Now
Zacks · 2d ago
UiPath, monday.com, Amplitude, Doximity, and Sprinklr Shares Skyrocket, What You Need To Know
StockStory · 6d ago
Doximity (DOCS) Gains As Market Dips: What You Should Know
Zacks · 7d ago
Can Doximity Keep Shrinking Its Share Count Through Its AI Investment Year?
Trefis · 13d ago
3 Profitable Stocks with Warning Signs
StockStory · 13d ago
What Doximity (DOCS)'s Bedside Bench AI Benchmark Launch Means For Shareholders
Simply Wall St. · 14d ago
Doximity Named Leading Clinical AI Benchmark in Fireworks’ Cross-Industry Index
Business Wire · 14d ago
PRIVATE STRATEGY · BY QUALIFICATION
The same data. A different seat.
The research you are reading is the input layer for a discretionary options program we run for a small number of qualified investors. Minimum $1,000,000.